EHMA 2022 Conference Programme

Two years into facing the COVID-19 pandemic, health systems are analysing their response and working on improving their preparedness for future challenges. The pandemic highlighted the need for forward-looking leadership, as well as the importance of investing in people to ensure a sustainable, healthy future.

At this year’s conference, we will discuss how health leaders can address some of the most pressing challenges health systems are currently facing. We will also explore innovative solutions that have been implemented at individual, organisational or systems level to increase the resilience, readiness and sustainability of health services.

Institutional greetings

• Dr Axel Kaehne, President of the European Health Management Association (EHMA); Reader Health Services Research, Edge Hill University; Director, Evaluation and Policy Analysis Unit of Edge Hill University; Editor in Chief, Journal of Integrated Care (Emerald), United Kingdom
• Prof Todorka Kostadinova, Vice-President of the European Health Management Association (EHMA); Vice Rector for International Relations, Quality and Accreditation at Medical University Varna, Bulgaria
• Prof Dr Kris Vanhaecht, Associate Professor Quality in Healthcare, Leuven Institute for Healthcare Policy, University of Leuven KU Leuven, Belgium
• Prof Dr Dirk Ramaekers, Head of the health crisis management team at the Belgian Ministry of Health, Board member of HERA and Head of the Task Force COVID-19 Vaccination, Belgium

Facilitator

Prof Dr Dirk De Ridder, Head of the research unit for Healthcare Policy, Leuven Institute for Healthcare Policy, University of Leuven KU Leuven, Belgium

People-centredness extends the concept of patients within the healthcare setting to individuals, families, communities, and society and focus on population empowerment, as well as social services and broader health determinants. With the increasing demands on health services, rapidly changing context, the adoption of technological innovations, and the demand for more complex care, health leaders are having to transition more quickly and effectively to practicing and supporting people-centred care.

How can health systems manage better partnerships between patients and healthcare providers and balance evidence-based healthcare management and patient preferences? How are processes such as value-based healthcare and integrated care achieving better patient reported outcomes and experiences? What types of multisectoral collaborations can support holistic practices and decision-making?

Opening address

• Ms Elisabeth Kasilingam – Chief Executive Officer, European Multiple Sclerosis Platform, Belgium

Keynote

Ms Maya Matthews, Head of Unit B1: Performance of national health systems, DG SANTE, European Commission

Panel discussion with

• Dr Elly Breedveld, Director, Stichting Perspekt, The Netherlands
• Prof Dr Kris Vanhaecht, Associate Professor in Quality in Healthcare, Leuven University, Leuven Institute for Healthcare Policy, Faculty of Medicine

Facilitator
Prof Dr Dirk De Ridder, Head of the research unit for Healthcare Policy, Leuven Institute for Healthcare Policy, University of Leuven KU Leuven, Belgium

The following Posters will be presented:

• CIV-MIL Integration in the transformation of the EU healthcare network: a dual-gain strategy
  Dr Jacopo Frassini, Doctrine SO2, NATO Centre of Excellence for Military Medicine, Italy
• Improving access to the school medicine network in Romania: drawbacks and promises
  Ms Simona Ciotlaus, Master Student, Babes-Bolyai University, Romania
• Eliciting and evaluating an initial program theory for a health policy intervention: realist evaluation approach
  Mr Märt Vesinurm, PhD Student, Aalto University, Finland
• The Leadership Attitudes and Beliefs of Healthcare Management Students: What Gen Z and Millennials Think about Leadership and Organizations
  Ms Melis Catikkas, PhD Student, Acibadem University, Turkey
• More haste, less speed? A brief history of electronic health records (EHRs) implementation in Germany to provide perspectives
  Ms Tugce Schmitt, Researcher, Maastricht University, The Netherlands
• Shaping and Sustaining the NHS Clinical Workforce of Tomorrow: Facilitating Recruitment and Optimising Retention of International Medical Graduates (IMGs) through Support Strategy Development
  Dr William Sacre, Doctor, University Hospitals Sussex, United Kingdom
• Environmental Sustainability of Hospital Buildings. Literature Review
  Mr Daniel Teixeira da Silva, Researcher, Universidade de Évora, Portugal
• Fresh insights into the work of community (home care) nurses using labour process theory
  Ms Lise Elliott, Senior Lecturer in Healthcare Management, University of Manchester, United Kingdom
• Proposals on education and working conditions of management of health care institutions in the Republic of Croatia
  Mr. Dražen Jurković, MD, MSc, Director, Croatian Health Employers’ Association, Zagreb, Croatia

Over the past two years, the need for a rapid exchange of population health and health policy information across countries has become more pressing than ever before. An informed comparison of data across Europe can firstly provide crucial leads to researchers as they model future scenarios and assess the impact of public health policy measures. Secondly, it can inform national decision-makers as they conceptualise responses to an ever-evolving threat, and not least citizens trying to navigate daily life and travel across the European region under unprecedented circumstances.

However, both gaps in infrastructure for rapid and effective cross-country exchange of health information have presented obstacles since long before the pandemic. Recently, leaps and bounds have been made in building new structures as well strengthening existing platforms for data and knowledge transfer and presentation – from the European Health Information Portal by PHIRI, to the ECDC and JRC joint Rapid Response Measures Database, and the Re-open EU platform. One important effect was that most of these organizations allocated specific experts to contribute to this task. At the same time, significant challenges remain. What will pan-European health information infrastructure look like as the pandemic evolves, and can we transfer the lessons learned into sustainable strategies to be better prepared for the next pandemic?

In this session, pivotal stakeholders will present their research, platforms and approaches, explore synergies between different sources and dissemination methods for cross-country health information exchange, and discuss how better information can further international impact assessment of policy measures and ultimately aid in addressing shared threats with cohesive action. Join us to envision a sustainable and effective future for European health information sharing – during the COVID-19 pandemic and beyond!

Speakers

• Ms Favelle Lamb, Expert in Emergency Preparedness and Response, European Centre for Disease Prevention and Control (ECDC), Sweden
• Mr Manuel Palazuelos Martinez, Re-Open EU Coordinator, Joint Research Centre (JRC), European Commission, Belgium
• Dr Marilia Paulo, Senior Researcher, Comprehensive Health Research Center, Nova Medical School, Universidade Nova de Lisboa (UNL), Portugal
• Dr Hanna Tolonen, Research Programme Director, Finnish Institute for Health and Welfare (THL), Finland

Facilitator
Dr Matthias Wismar, Programme Manager, European Observatory on Health Systems and Policies, Belgium

This session is organised in collaboration with Gesundheit Österreich GmbH (GÖG) and the PHIRI project that receives funding under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 101018317).

The abstracts in this session address the impact on and responses of the health workforce in the context of COVID-19, and discuss how the pandemic has and will initiate change.

The following abstracts will be presented:

• Multidisciplinary teams and quality of care: the experience of breast units during COVID-19
  Dr Eugenio Di Brino, Università Cattolica del Sacro Cuore, Rome, Italy
• Implications for health system reform, workforce recovery and rebuilding: Lessons from the Great Recession and COVID-19
  Dr Padraic Fleming, Trinity College Dublin, the University of Dublin, Dublin, Ireland
• The pandemic as initiator for change: findings from the conceptual phase of a user experience pilot in a university hospital
  Ms Charlotte Jewell, Université de Liège, Liège, Belgium
• Creating sustainable working environments: working hours of Junior Doctors during COVID-19 pandemic
  Dr Francisco Ribeiro Mourao, European Junior Doctors, Brussels, Belgium
  
• The impact of COVID-19 on postgraduate training in European Junior Doctors
  Dr Ellen McCourt, European Junior Doctors Association, Brussels, Belgium
• The evolving impact on healthcare professionals during three COVID-19 waves. A study in the Flemish healthcare workforce
  Prof Kris Vanhaecht, KU Leuven, Leuven, Belgium

In this session, the presenters will be addressing the challenges posed by the climate crisis.  The research presented will outline changes in health workforce operations and capacity, including task-shifting, towards more sustainable healthcare leadership and delivery.

The following abstracts will be presented:

• The optimised patient treatment initiative: a proof of concept from immunology for a sustainable healthcare system
  Ms Sarah Alulis, Janssen-Cilag, Birkerød, Denmark
• Task sharing among healthcare professionals for sustainable health systems
  Prof Régis Blais, School of Public Health, University of Montreal, Montreal, Canada
• OPEN public hospitals’ eyes to INNOVATION
  Dr Ines Ferreira, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
• Health workforce for future: actions to strengthening the capacity of the health workforce in era of climate crisis
  Prof Dr Marija Jevtic Faculty of Medicine University of Novi Sad, Novi Sad, Serbia
• Task Shifting in practice – Case study of the digital pathology in Hungary
  Dr Eszter Kovacs, Semmelweis University, Budapest, Hungary
• Knowledge, skills and competency required for task shifting: the TaSHI-project
  Dr Vibeke Sundling, University of South-Eastern Norway, Drammen, Norway

In this session the presenters will address innovations and challenges towards the development of patient care pathways and patient centrism, as well as the differences in perception of healthcare delivery by health professionals as compared to patients.

The following abstracts will be presented:

• Digital workflow of the breast cancer care by artificial intelligence and distributed ledger technology application to enhance patient centrism and data sovereignty – a model based on the regional breast cancer care network of a German university hospital
  MSc Sebastian Griewing, Institute for Health Care Management e.V., Philipps-University Marburg, Marburg, Germany
• The complexity of co-designing a transmural care pathway for patients treated with oral anticancer drugs: a qualitative study
  Ms Ilyse Kenis, Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium
• The impacts on the daily life of the person with Type 2 Diabetes Mellitus (T2DM) – a comparative analysis between the perceptions of health professionals and people living with T2DM
  Prof. Ana Rita Pedro, NOVA National School of Public Health, Comprehensive Health Research Centre, Lisbon, Portugal
• Integrated care and patient’s satisfaction: evidence from the case of people with epilepsy
  Prof. Stefano Villa, Ph.D., Full Professor of Business Administration, Head of CERISMAS Operations Management Area, Catholic University of Sacred Heart, Milan, Italy
• Managing polypharmacy in patients with chronic diseases using innovative solutions (Gatekeeper project)
  Ms. Irati Erreguerena Redondo, Kronikgune Institute for Health Services Research, Bilbao, Spain

Lung cancer is the main cause of cancer-related deaths in Europe, and its burden will remain high for several decades to come. Even though smoking rates are gradually declining, people who used to smoke remain at high risk of lung cancer for many years after quitting, and environmental factors such as air pollution are a growing cause of lung cancer in the entire population.

We have the means to reduce the burden of lung cancer on our society, but it will require a comprehensive and integrated approach. Importantly, we need to dispel the perception that lung cancer is a self-inflicted condition. Early detection needs to be enhanced by implementing large-scale screening programmes that target high-risk individuals, alongside smoking cessation programmes. Complementary approaches, such as incidental pulmonary nodule identification, management protocols and rapid referral pathways from primary to secondary care, are also important to improve early detection. Improvements to lung cancer care pathways are needed to ensure all people have access to multidisciplinary care that encompasses specialist diagnosis, personalised treatments, and palliative and survivorship care. Finally, targeted efforts are required to reduce geographical and socioeconomic disparities in access and outcomes.

Making these changes can deliver benefits beyond lung cancer. Tackling lung cancer can help countries progress towards reducing the overall burden of NCDs on their societies and contribute to greater health system sustainability. With the implementation of Europe’s Beating Cancer Plan and as we look to post-COVID recovery, we have the opportunity to put in place what is needed to improve outcomes for people with lung cancer and reduce the burden the condition poses on our societies.¹

Speakers

• Dr Dariusz Adamczewski, Director Government Affairs & Policy at Johnson&Johnson, Belgium
• Dr Alexandre Lourenço, President, Association of Portuguese Hospital Managers; Hospital Administrator, Coimbra University and Hospital Centre, Portugal
• MEP Manuel Pizarro, Co-Chair of the MEP Lung Group, European Parliament, Portugal (video contribution)
• Dr Joan Prades, Researcher, Catalan Cancer Strategy, Health Department; Associate Professor, University of Barcelona (UB), Spain
• Dr Suzanne Wait, Managing Director, The Health Policy Partnership, United Kingdom

Facilitator

• Ms Sara Doguelli, Graduate in International Health and Social Management at the Management Center Innsbruck (MCI), Austria

This session is organised in collaboration with Johnson&Johnson.

Vaccines are recognised as one of the most cost-effective public health interventions for preventing infectious diseases. Each year, vaccination stops 2.7 million people worldwide from getting measles, one million from getting pertussis and two million babies from getting tetanus.

However, are we really aware of what it takes to bring a safe and efficacious vaccine to the market and how many different ‘actors’ can impact the process? The vaccine ecosystem is an organism/community made up of different elements which interact with each other and their environment. This means that actions in one part of the ecosystem will have consequences elsewhere, sometimes upsetting a delicate balance. Decisions on prioritisation of new pathogens for research and development (R&D), regulatory requirements, manufacturing and supply capacity, industrial and technology policies, procurement, pricing policies, forecasting, and stockpiling practices, and financing of vaccination programmes, all impact access to vaccines globally and in a given country. Ultimately, these components should lead to a predictable and sustainable supply of innovative, qualitative, and affordable vaccines to meet public health needs. This session aims to help the audience understand and recognise the many different components of the vaccine ecosystem, and how they are all interconnected.

The session is an innovative role-play where the audience can ‘switch hats’ and act as representative of one of the eight stakeholders group defined as driving forces of the European vaccine ecosystem: civil society, EU institutions, Ministries of Health, healthcare professionals, manufacturers, procurement actors, media and regulators. The session will showcase how the different groups of stakeholders are extremely dependent on each other’s support to achieve their goals and on how any action has a tangible impact on the other drivers of the vaccines system – as coverage rates, access, supply, affordability.

Opening keynote address by

• Prof Americo Cicchetti, Director of the Graduate School of Health Economics and Management (ALTEMS); Professor of Management at Universita’ Cattolica del Sacro Cuore, Italy

Panel discussion with

• Prof Sandra C. Buttigieg, Head of Department of Health Systems Management and Leadership, University of Malta
• Prof Americo Cicchetti, Director of the Graduate School of Health Economics and Management (ALTEMS); Professor of Management at Universita’ Cattolica del Sacro Cuore, Italy

* For logistical reasons, this session requires a prior expression of interest. If you wish to attend this session, while at the EHMA Conference, please contact us at federica.margheri@ehma.org

This session is organised in collaboration with MSD and Sanofi.

In this session the presenters will be discussing new models of integrating digital innovation into healthcare delivery and management, as well as barriers and determinants of technology usage in healthcare and hospital settings.

The following abstracts will be presented:

• Virtual action learning in healthcare leadership development programmes
  Ms Helen Baxter, University of Manchester, Manchester, United Kingdom
• Technology and innovation adoption in healthcare and management literature: a shared or different vision?
  PhD student Francesca De Domenico, University of Messina, Messina, Italy
• Digital therapies access in Italy: is it a problem of cost or literacy?
  PhD student Marzia Di Marcantonio, Università Cattolica del Sacro Cuore, Roma, Italy
• Implementation of eHealth solutions in municipal healthcare and hospital settings through a new structured approach to the implementation process. What works for whom, in which circumstances, and why? A realist evaluation
  PhD student Susanne Eriksen, Western Norway University of Applied Sciences, Haugesund, Norway
• Exploring barriers and determinants of technology adoption in the health sector
  Dr Guido Noto, University of Messina, Messina, Italy
• Artificial intelligence transforms human liquid biopsies analysis
  Dr Manlio Vinciguerra, Medical University of Varna, Varna, Bulgaria

This session will be moderate by Prof Jill McCarthy, Associate Professor at University of Manchester, United Kingdom 

This session takes a value-based healthcare perspective on governance and leadership, and presenters will be discussing frameworks, development of indicators, implementation and the performance of patient-centred healthcare.

The following abstracts will be presented:

• Implementing patient-reported indicators: first experiences with the International Survey of People Living with Chronic Conditions (PaRIS survey)|
  Dr Dolf de Boer, Nivel, Utrecht, Netherlands
• Locum doctors and patient and carer experiences of access and continuity of care
  Dr Jane Ferguson, University of Manchester, Manchester, United Kingdom
• Does value-based healthcare support patient-centred care?
  MD Martha Kidanemariam, Leiden University Medical Center, Leiden, Netherlands
• RITMOCORE – Creating value in patient centred care by aligning the supply chain with service provision
  Dr. Jordi Mercé, Arrhythmia Unit, Hospital Universitari de Bellvitge, L’Hospitalet, Barcelona, Spain
• A community-first framework for social value: a realist review
  Dr Crispen Sachikonye, University of Manchester, Manchester, United Kingdom
• Managing the performance of value-based healthcare: insights and recommendations
  Dr Hilco van Elten, Erasmus School of Health Policy & Management, Rotterdam, Netherlands

In this session the presenters will be discussing a broad array of topics, ranging from clinical and business leadership to quality of care policy, costing in value-based healthcare, to environmental sustainability in healthcare institutions, as well as conditions for third sector contributions to health systems.

The following abstracts will be presented:

• The future of hospital quality of care policy: a multi-stakeholder discrete choice experiment in Flanders, Belgium
  PhD candidate Jonas Brouwers, Leuven Institute for healthcare policy (LIHP), Leuven, Belgium
• Efficiency of environmental measures in reducing energy and water consumption and waste production using Stochastic Frontier Analysis – the reality of Portuguese healthcare institutions
  Dr José Chen-Xu, National School of Public Health, NOVA University of Lisbon, Lisbon, Portugal
• Effective use of data for clinical and business leadership: An international comparative study in Europe, US and Canada
  Mr Damir Ivankovic, Department of Public and Occupational Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health research institute, Amsterdam, Netherlands
• Costing in value-based healthcare – science or fiction? A systematic review
  Ms Maura Leusder, Erasmus University Rotterdam, Rotterdam, Netherlands
• Some organisational conditions for developing third sector contributions to health systems: evidence from England
  Prof Rod Sheaff, University of Plymouth, Plymouth, United Kingdom

During the cocktail, we are pleased to host a performance of the Brussels Young Adult Choir – BYAC, a mixed group of professional and amateur singers between 25 and 35 years old conducted by Johannes Dewilde, renowned worldwide for his choral expertise and musicality.

EHMA Programme Directors’ Group Networking Event

Excellence in post-graduate health management programmes was a key-driver behind the establishment of EHMA and it remains a principal focal point today.

EHMA has a well-established Programme Directors’ Group (PD Group) that brings together Programme and Course Directors, Heads of Department, Deans to help ensure that taught programmes continue to provide the highest quality education for health managers, healthcare professionals and other stakeholders.

At #EHMA2022, the Programme Directors’ Group will meet again in person after a few years of hiatus due to the pandemic. Under the chairmanship of Prof Ann Mahon, University of Manchester, the Group will welcome those who have previously been involved and new members are warmly welcomed.

This is an opportunity to network with other programme directors or course leaders in the area of healthcare management education. As well as networking, it is an opportunity to introduce the March 2023 PD workshop which will focus on lessons post COVID, opportunities for collaborative working and networking.

If you are interested in joining the event, please contact us at laura.cande@ehma.org

One lesson coming from the COVID-19 pandemic is that health systems had a central role addressing the crisis. The pandemic produced a shock to European health systems that was both specific to the crisis but which also exacerbated pre-existing challenges that undermine good performance of health systems. Drawing on the evidence gathered from the State of Health in the EU (SoHEU) Country Health Profiles and the European Commission’s accompanying Companion report, launched in Dec 2021, this workshop focuses on two key areas in which health systems can build stronger and more resilient health systems: locking in the advantages of digital innovation in health care delivery to ensure access and rethinking health workforce strategies and planning after the COVID-19 pandemic.

Speakers

• Ms Anna Sagan, Research Fellow, European Observatory on Health Systems and Policies; London School of Economics and Political Science, UK
• Mr Gaetan Lafortune, Senior Economist, OECD Health Division, France
• Mr Federico Pratellesi, Policy Officer, DG SANTE, European Commission, Belgium

Facilitator

• Dr Matthias Wismar, Programme Manager, European Observatory on Health Systems and Policies, Belgium

This session is organised in collaboration with the European Observatory on Health Systems and Policies.

This session focuses on understanding the status quo and sustainability, as well as the improvement of care processes and the cycle of care for elderly, and in the treatment of variety of health conditions including acute ischemic stroke, dermatological, rheumatological, and gastroenterological diseases, colonic cancer.

The following abstracts will be presented:

• Co-creation roadmap towards sustainable quality of care: a multi-method study
  MSc, PhD Cand. Fien Claessens, Leuven Institute for Healthcare Policy – Department of Public Health, KU Leuven – University of Leuven, Leuven, Belgium
• Impact of an improvement collaborative on adherence to an ERAS protocol in elective colonic cancer surgery: a multicenter study
  Dr Ellen Coeckelberghs, Leuven Institute for Healthcare Policy, KU Leuven – University of Leuven, Leuven, Belgium
• Biosimilars for the treatment of dermatological, rheumatological and gastroenterological diseases: patterns of use and economic advantages
  Ms Lucrezia Ferrario, LIUC University and LIUC Business School, Castellanza, Italy
• How standardised are the care processes for acute ischemic stroke in Flemish hospitals?
  Ms Charlotte Lens, Leuven Institute for Healthcare Policy – Department of Public Health, KU Leuven, Leuven, Belgium
• Re-design elderly care across the full cycle of care: evidence from an Italian benchmarking study
  Ms Rossella Pellegrino, PhD student in Management & Innovation, Researcher at CERISMAS, Catholic University of Sacred Heart, Milan, Italy

In this session the needs of the health workforce will be addressed with a specific focus on, but not limited to, nurses, with regards to clinical leadership, mental health support, inclusion, and engagement.

The following abstracts will be presented:

• Importance of clinical leadership in crossing medical specialist boundaries
  Ms Anoek Braam, Erasmus School of Health Policy and Management, Rotterdam, Netherlands
• “The illusion of influence”: how mechanisms of exclusion can hinder nurses’ voice behavior
  MSc Karin Kee, Vrije Universiteit, Amsterdam, Netherlands
• Integrating the needs of small medical specialties in future health workforce management: the case of rheumatology in Germany
  Dr Ellen Kuhlmann, Hannover Medical School, Hannover, Germany
• Nurses has left the building – Broken psychological contracts in health and social care among nursing professionals
  PhD Minna Kaarakainen, University of Eastern Finland, Kuopio, Finland
• Breaking perceptions: how to effectively support health professionals to participate in research projects
  MSc Liliana Sousa, EEG- University of Minho, Braga, Portugal
• Use it or lose it? Exploring reasons for the low uptake of formal psychosocial support during a crisis
  MSc Frank van de Baan, Maastricht University, Maastricht, Netherlands

Respiratory Syncytial Virus (RSV) accounts for 63% of acute respiratory infections in infants and is the leading cause of hospitalisation for infants in their first year of life. The severity of RSV is unpredictable, and its burden extends beyond the hospital. There is no active treatment for RSV; care is primarily supportive and RSV-infected infants are expected to clear the infection on their own. Prior to COVID-19, RSV was the leading respiratory virus with implications for both elderly and infant populations.

The COVID-19 pandemic has raised heightened awareness of the public health threat of respiratory illnesses and the need for new approaches to infection control and prevention. Therefore, there are compelling reasons to prioritise RSV treatment and prevention and raise public policy awareness on its public health impact in pediatric outpatient and inpatient settings.

This session begins by setting the scene on the burden of RSV infections drawing on evidence gathered in the Europe-wide survey conducted by EHMA, and reports on the burden of pediatric RSV on health systems in Europe.

Speakers

• Dr João Breda PhD MPH MBA, Head, WHO Athens Quality of Care and Patient Safety Office & Special Adviser for the Regional Director, Division of Country Health Policies and Systems, WHO Greece
• Prof Susanna Esposito, Full Professor of Pediatrics, University of Parma, Director of Pediatric Clinic, Pietro Barilla Children’s Hospital, WAidid President, Parma, Italy
• Mr Richard Osei Yeboah, Centre for Global Health, University of Edinburgh, United Kingdom
• Dr Francisco Ribeiro-Mourão, Pediatrician, Centro Materno Infantildo Norte (CMIN), Porto Centre and University Hospital; Treasurer, European Junior Doctors, Portugal

Facilitator
Prof Federico Lega, Professor of Health Administration, University of Milan, Italy

This session is organised in collaboration with  Sanofi.

This session will feature presentations of the shortlisted abstracts that are competing for the Karolinska Medical Management Centre (MMC) & EHMA Research Award, an annual award for the best contribution associated with a doctoral thesis related to health management.

The following abstracts will be presented:

• Prevalence and predictors of care left undone among physicians in acute care hospitals across six European countries.
  Mr Simon Dello, Leuven Institute for Healthcare Policy, KU Leuven, Leuven, Belgium
• Improving health performance through clinical risk management: the clinical path within the Intensive Care Units
  Dr Anna Roberta Gagliardi, Department of Economics, University of Foggia, Foggia, Italy
• Cost-effectiveness analysis of proximal femoral nail and bipolar hemiarthroplasty in hip fracture surgery
  Ms Gamze Kutlu, Ankara University, Ankara, Turkey
• Pharmacists in the strategic leadership of manufacturing pharmaceutical companies
  Ms Nsovo Mayimele, Tshwane University of Technology, Pretoria, South Africa; University of the Witwatersrand, Johannesburg, South Africa
• Unwarranted between-hospital variation in the vital few patient outcomes mortality, readmission and prolonged length of stay as a trigger for setting quality priorities. The urology case study.
  Ms Astrid Van Wilder, Leuven Institute for Healthcare Policy, KU Leuven, Leuven, Belgium

This session will be moderated by Prof Sandra C. Buttigieg, Head of Department of Health Systems Management and Leadership, University of Malta

Facilitating access to healthcare implies improving the affordability, accessibility, acceptability, availability, and adequacy of care services. Effective management, operations and practice are key to reduce waste of time and resources. The abstracts in this session explore methods of improving access, delivery and outcomes of healthcare through improved management, operations and practice.

The following abstracts will be presented:

• Epidemiology and management of Heart Failure in 10 European countries
  Ms Pascale Brasseur, Miracor Medical, Awans, Belgium
• Towards achieving full potential for community health care in Romania – an analysis of current evidence
  Ms Monica Georgiana Brînzac, Department of Public Health, Faculty of Political, Administrative and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
• Factors influencing automated dispensing solutions for in-hospital medications: experiences, perceptions and economic evaluation in six European Countries
  Dr Lucrezia Ferrario,  Carlo Cattaneo – LIUC University and LIUC Business School, Castellanza, Italy
• Challenges for structurally achieving value-based healthcare: a multi-method case study in a setting with ‘perfect’ preconditions
  Dr Bart Noort, University of Groningen, Groningen, Netherlands
• Measuring the outcomes of physical rehabilitation in early-stage Alzheimer’s patients: a feasibility study
  Ms Laura Pitkänen, University of Helsinki, Helsinki, Finland

In this session the presenters will share their findings on enhancing patient safety, developing effective case management and improving access to healthcare through digitalization. The session will view the digital transformation from the perspective of the patients and the health care providers.

The following abstracts will be presented:

• Establishment of an innovation centre within an Irish acute hospital
  Dr Natalie Cole, Tallaght University Hospital, Dublin, Ireland
• WOW – A step towards domiciliary hospitalisation
  PhD Inês Antunes Ferreira, CHUC, Coimbra, Portugal
• Patient-centred medication management: How to enhance patient safety and reduce work burden for medical staff by digitalized closed-loop cabinets
  Prof Dr Wilfried von Eiff, CKM Center for Hospital Management, Muenster, Germany
• A novel innovation in provision of public health services: A primary care Joint Venture enabling better access to care with a new digital services platform and 24/7 Digital Clinic
  Joonas Turunen, Mehiläinen, Helsinki, Finland

In the European Union (EU), 34 million adults live with a disabling hearing loss, of which 22.6 million are not treated.  When left untreated, hearing loss reduces a person’s ability to communicate with others but also impacts speech and language development, educational outcomes, quality of life, employment, relationships, and cognition. Untreated hearing loss has an estimated economic impact of 185 billion euros each year in the EU.

In Europe, one third of people aged over 60 are living with a disabling hearing loss. Ageing is the most common contributing factor to hearing loss and hearing loss is in turn, often seen as a normal part of ageing. This session explores beyond the obvious to discuss the impact of age-related hearing loss from the individual to the health systems level.

Opening address

• MEP Alex Agius Saliba, European Parliament, Malta (video contribution)

Keynote

• Prof em. Dr Paul Van de Heyning, Vice-Chairman, HEARRING Group, Antwerp University Hospital, Belgium

Panel discussion with

• Dr Patrick D’Haese MBA PhD, Corporate Director of Awareness and Public Affairs, MED-EL Medical Electronics, Belgium
• Dr Axel Kaehne, Reader Health Services Research, Edge Hill University; Director, Evaluation and Policy Analysis Unit of Edge Hill University; Editor in Chief, Journal of Integrated Care (Emerald); President, European Health Management Association, United Kingdom
• Ms Yuliya Shcherbina, Market Development Lead, International Accreditation, Health Assessment Europe and Accreditation Canada, Belgium

Facilitator
Ms Emma Cracknell, Senior Vice President, Director, Head of Healthcare, FleishmanHillard; Hearing Health Forum EU, Belgium

This session is organised in collaboration with the Hearing Health Forum EU and supported by MED-EL Medical Electronics

The following Posters will be presented:

• New approaches to manage the digital health transformation and boost the innovation adoption in healthcare settings
  Mr Vicente Traver, Research Director, Universitat Politecnica de Valencia, Spain
• Human resource management in home care: Managing people for safe care at the front-line of the pandemic
  Mr Nguyen Anh Thoai Le, PhD Student, University of Nottingham, United Kingdom
• Professionals’ perceptions on interprofessional collaboration in Value-based Healthcare teams: a mixed-method study
  Ms Dorine van Staalduinen, PhD Student, Leiden University Medical Center, The Netherlands
• Technostress: a review in Healthcare
  Ms Alessandra Pernice, PhD Student, ALTEMS – Università Cattolica del Sacro Cuore di Roma, Italy
• IoT for medical waste management: the case of a Swiss multisite hospital
  Mr Federico Umberto Mion, Head of Finance & Administration, Regional Hospital of Lugano, Switzerland
• The juggling boundary work of social community teams to stay legitimate in a multi-stakeholder context
  Mr Martian Slagter, PhD Candidate, University of Groningen, The Netherlands
• Patient Reported Outcomes (PROs) – a tool to support clinical practice: an organizational change in an oncological public hospital
  Ms Patrícia Redondo, Manager, IPO-Porto, Portugal; Ms Salomé Gonçalves-Monteiro, Data Analyst , IPO-Porto, Portugal
• ANTI-SUPERBUGS PCP. A cross-border joint action to improve healthcare-associated infections’ prevention and control systems
  Mr Enric Limon, Coordinator VINCat Program, Institut Català d’Oncologia, Spain
• Towards zero waste: environmentally sustainable waste management solutions for hospitals – An innovative procurement approach
  Mr Joaquim Duarte, Senior Sustainable Waste Manager, University Hospitals Bristol and Weston NHS Foundation Trust

Over the last years, national health systems and pan-European health authorities have worked tirelessly to progress towards managing the pandemic. They have created recovery plans and increasingly worked to strengthen the resilience of their health systems and sustainability of their resources in an ever-changing context. Many lessons have been identified as a result of facing the pandemic and will be essential in the implementation of changes for the future.

What are the key lessons learnt from COVID-19 across European health systems? How can health systems organise and health services adapt for a post-COVID context? How have European and national health systems implemented the lessons learnt from the past two years?

Keynote
Dr Matthias Wismar
Programme Manager, European Observatory on Health Systems and Policies, Belgium

Panel discussion with

• Dr Eszter Kovacs, Assistant Professor, Health Workforce Planning Knowledge Centre, Semmelweis University Health Services Management Training Centre, Hungary
• Ms Laura Marchetti, Policy Manager, Mental Health Europe
• Prof Dr Dirk Ramaekers, Head of the health crisis management team at the Belgian Ministry of Health, Board member of HERA and Head of the Task Force COVID-19 Vaccination, Belgium
• Mr Luca Rossi, Head of Unit SG.RECOVER.B3 – Social Affairs, Education, Health at the Recovery and Resilience Task Force of the European Commission

Facilitator
Prof Dr Kris Vanhaecht, Associate Professor in Quality in Healthcare, Leuven University, Leuven Institute for Healthcare Policy, Faculty of Medicine

COVID-19 health systems responses have demonstrated the importance of a European Health Union (EHU). Cross-border healthcare is clearly part of such an EHU: it adds value for border regions and it empowers citizens when going abroad as students, workers, pensioners, tourists or patients. It resolves capacity issues, improves access and helps patients with rare diseases. To clarify terms and conditions of cross-border healthcare the patients’ rights directive (Directive 2011/24/EU) was introduced in 2011. It also introduced ‘cooperation in health care’ including supporting assistance and cooperation, recognition of prescriptions issued in another Member State, the European Reference Networks, action in the area of rare diseases, eHealth, and cooperation on Health Technology Assessment (HTA). Is this good enough, or do we need to make another effort toward EHU in cross-border healthcare?

Speakers

• Dr Eleanor Brooks, Lecturer in Health Policy, Global Health Policy Unit (GHPU), School of Social and Political Science, University of Edinburgh, United Kingdo
• Ms Isabel De La Mata Barranco, Principal Adviser, DG SANTE, European Commission, Belgium
• Dr Nick Fahy, Health and Wellbeing Research Group Director, RAND Europe
• Prof Scott Greer, Professor of Health Management and Policy, Global Public Health, and Political Science, University of Michigan; Senior Expert Advisor on Health Governance, European Observatory on Health Systems and Policies, USA

Facilitator

• Dr Matthias Wismar, Programme Manager, European Observatory on Health Systems and Policies, Belgium

This session is organised in collaboration with the European Observatory on Health Systems and Policies.

In this abstract session, various research will be presented on the disruptive effects of the pandemic as well as other crises and disasters. Presenters will share the perceptions of health care providers as well as patients, related to health delivery and receipt, and the digital and operational transformations triggered by COVID-19.

The following abstracts will be presented:

• Shared Decision-Making (SDM) during a pandemic – Evidence from Cyprus
  Dr Chris Bachtsetzis, Arrowe Park Hospital, Wirral University Teaching Hospital, Liverpool, United Kingdom
• Breast unit safety during covid-19 pandemic: difference among coordinators and patients’ perceptions
  Mr Eugenio Di Brino, Università Cattolica Del Sacro Cuore, Rome, Italy
• INTREPID: Artificial Intelligence in disasters, the future is already here
  Ms Marta Burgos Gonzalez, Spanish School of Rescue and Detection with Dogs (ESDP), Madrid, Spain
• Disruptive effects of COVID-19: An exploration of EU country responses and lessons for workforce mobilisation
  Dr Gareth Rees, ESAN University, Lima, Peru
• Digital transformation in the era of COVID-19: the case of Greece
  MBA Achillefs Vratimos, National and Kapodistrian University of Athens, Athens, Greece

In this abstract session the presenters will address the wellbeing and future of the health workforce. Reflections will be offered on topics such as planning for the future to build resilient health systems, developing professional competency frameworks, and the implementation and enactment of policy in practice.

The following abstracts will be presented:

• Towards resilient health systems: a youth perspective to impulse the wellbeing of healthcare workers
  Ms Audrey Fontaine, European Health Parliament, Brussels, Belgium
• Status of nursing and midwifery in the WHO European Region
  Dr Sule Kurt, KU Leuven, Leuven, Belgium
• Medical workforce planning of the future: trends from Junior Doctor’s eyes after the pandemic
  Dr Francisco Ribeiro Mourao, European Junior Doctors, Brussels, Belgium
• Health policy implementation: how do private providers and health workers adapt or enact policy in practice?
  Dr Sarah Willis, University of Manchester, Manchester, United Kingdom
• International comparison of professional competency frameworks for nurses: A document analysis
  Ms Renate Wit, Nivel, Utrecht, Netherlands

Medicines are crucial to save human lives and improve wellbeing. However, when prescribed, used, or disposed inappropriately, they can impact human health and severely impact wildlife and ecosystems. Medicines can impact the environment through CO2 emissions emitted by the supply chain of medicines or through pharmaceutical effluents from the production and usage of medicines. Pharmaceutical wastewater contain an important concentration of antibiotic resistance genes and their continuous presence in the environment can lead to antimicrobial resistance. In the EU/EEA alone, there is an estimated 33 000 annual human deaths linked to antibiotic-resistant bacteria.

Multisectoral engagement across the medicine’s lifecycle is therefore urgently needed to address this matter. So how can health managers play their part?

This session will discuss strategies and best practices that health managers can implement to reduce the environmental impact of medicines at various stages of the medicine’s lifecycle. In particular, it will dive into actions that health managers can take at the procurement, logistic planning and distribution, prescription, consumption and use, and disposal stages.

Opening address by

• Ms Emmi Weller, Policy Officer, European Health Management Association (EHMA), Brussels

Panel discussion with

• Mr Joaquim Duarte, Senior Sustainable Waste Manager, University Hospitals Bristol and Weston NHS Foundation Trust
• Prof Dr Marija Jevtic, Health Manager, Full professor, Medical Faculty UNS, Scientific collaborator Université Libre de Bruxelles Research centre on Environmental and Occupational Health, EU Climate Pact Ambassador
• Dr Kirsty Reid, Director of Science Policy, European Federation of Pharmaceutical Industries and Associations (EFPIA)
  

Facilitator
Mr George Valiotis, Executive Director, European Health Management Association (EHMA)

This session is organised in collaboration with MSD.

The aging population and the burden of chronic conditions is increasing the demand for more comprehensive, efficient and smarter care. JADECARE (Joint Action on implementation of Digitally Enabled integrated person-centred CARE) intends to reinforce the capacity of health authorities to successfully address the transition to digitally enabled integrated person-centred care. It enables the transfer and adoption of four Good Practices (GP) to the contexts of 21 Next Adopters (NA) in Europe.

This workshop explores the factors to be addressed when transferring GP to heterogeneous health systems with different needs, aims and scopes. It features the core elements of the four GP of JADECARE, concerning integrated care, chronic conditions, self-care, prevention and population health that are being transferred. GP are: Basque Health strategy in ageing and chronicity: integrated care (Spain), Catalan open innovation hub on ICT-supported integrated care services for chronic patients (Spain), OptiMedis Model-Population-based integrated care (Germany), Digital roadmap towards an integrated health care sector (Denmark).

It will also highlight the experience of two of the 21 NA: Department for Self-determined Living of the German-speaking Community of Belgium (SELBM), Belgium (SELBM) and Croatian Institute of Public Health (CIPH)

Speakers

• Mr Kuno Strand Kudajewski, Project Manager, Region of Southern Denmark’s health innovation office, Denmark
• Ms Roberta Papa, Project Manager and Researcher, Regional Health Agency of Marche Region, Italy
• Mr Justin Rautenberg, Senior Manager Project Development, Optimedis, Germany
• Dr Josep Roca, Senior Researcher, August Pi i Sunyer Biomedical Research Institute, Spain

Facilitator
Mr Jon Txarramendieta, Kronikgune Institute for Health Services Research, Spain

This session is organised in collaboration with the Kronikgune Institute for Health Services Research and the Joint Action (JA) on implementation of digitally enabled integrated person-centered care (JADECARE) that is co-funded by the Third Health Programme of the European Union under Grant Agreement No. 951442 (HaDEA).

In this session focusing on value-based care, the presenters will address the topics of shifting perspective towards the patient, organising care around patients, value-based consultations and the determinants of clinical engagement in healthcare organisations.

The following abstracts will be presented:

• Towards a framework for organising care around patients, drawing on stories from the frontline of the NHS in England
  Prof Naomi Chambers, University of Manchester, Manchester, United Kingdom
• From a view of the hospital as a system to a view of the suffering patient
  Dr Gillie Gabay, Achva Academic College, Shikmim, Israel
• The concept and the determinants of clinical engagement in healthcare organisations: a scoping review
  Prof Federico Lega, Università degli Studi di Milano, SCIBIS, HEAD, Milan, Italy
• Expert consensus on value-based healthcare in the consultation room: a Delphi study
  ir. Veerle van Engen, Erasmus University Rotterdam, Rotterdam, Netherlands

In this session on governance and leadership, the presenters will introduce methods of communication and health management to improve healthcare access, delivery, outcomes, in addition to influencing factors and assessment methods of hospital performance and health outcomes.

The following abstracts will be presented:

• Health Management: evaluating the relationship between organizational factors, psychosocial risks at work, performance management and hospitals outcomes
  Professor Tania Gaspar, Lusiada University/CLISSIS, Lisbon, Portugal
• Effective use of data for clinical and business leadership: An international comparative study in Europe, US and Canada
  Mr Damir Ivanković, Department of Public and Occupational Health, Amsterdam UMC
• Digital transformation for increased access and improved management of diabetes and its complications
  Associate Prof, MD,MBA, PhD Nino Mikava, Business and Technology University, Tbilisi, Georgia
• Communicating research evidence to health and care boards
  Ms Sarah Parkinson, RAND Europe, Cambridge, United Kingdom
• Distance from a Reference Centre on complex cancer diseases: a proxy for poor outcomes? A mixed-methods study based on Catalonia (Spain)
  Professor Joan Prades, Catalan Cancer Strategy, Department of Health, Barcelona, Spain
• Does nursing leader’s collectivistic orientation contributes to team members’ patient safety behaviors – A multilevel model
  Dr Sarit Rashkovits, Yezzrel Valley College, Yezzrel Valley, Israel

In this session on finance and economics, the presenters will discuss the relationship between health care funding and innovation; the journey towards value based funding models; the economic impact of COVID-19 in the hospital setting and on the uptake of palliative and end-of-life care; and the search for better funding models.

The following abstracts will be presented:

• The influence of funding and reimbursement on healthcare product innovation: a comparative case study
  MSc Sanne Allers, Erasmus School of Health Policy and Management, Rotterdam, Netherlands
• A journey towards a Value-Based Health Care (VBHC) funding model for Lung Cancer: the FAROL (“lighthouse”) project
  MSc Marina Borges, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal
• Hospital economic burden of COVID-19 critically ill in the first year of pandemic – clinical, therapeutic and demographic cost correlated factors
  BSc Ana Craveiro, CHUPorto, Oporto, Portugal; Ms Susana Ferreira, Controler, Centro Hospitalar e Universitário do Porto, Portugal
• Factors affecting the end-of-life care and palliative care use among people aged 50 and older in Europe before and during the COVID-19 pandemic
  PhD Rui Dang, Westminster International University in Tashkent, Tashkent, Uzbekistan
• Local treatment of breast cancer: an HTA analysis comparing IORT and EBRT in the Italian setting
  Ms Lucrezia Bianca Ferrario, Carlo Cattaneo – LIUC University and LIUC Business School, Castellanza, Italy
• Educational interventions to reduce prescription and dispensing of antibiotics in primary care: a protocol for a systematic review of economic impact
  Prof Maria Teresa Herdeiro, Institute of Biomedicine (iBiMED), University of Aveiro, Aveiro, Portugal
• In search of a better health system funding model
  Prof Denise Santos, ESESFM, Lisbon, Portugal

Health systems face a broad range of evolving challenges and need to be dynamic to respond in ways that help them achieve their goals. While improving health and care systems is primarily the responsibility of Member States within the European Union (EU), the EU has a wide range of instruments that can potentially provide support; for most of them, health systems strengthening is not among the principal objectives. This can make it challenging for Member States to identify and make best use of the different support options. This session will provide an overview of available EU instruments, concrete examples of how EU countries have used them to address health system challenges, and insights into relevant priorities under EU4Health and Horizon Europe to help participants consider their own initiatives.

Speakers

• Ms Nicole Mauer, Technical Officer, European Observatory on Health Systems and Policies, Belgium
• Ms Sabrina Montante, Senior EU Policy Advisor, Istituto Superiore di Sanità Brussels Liaison Office, Italy
• Ms Solvejg Wallyn, Policy Officer, Flanders Agency for Care and Public Health, Belgium

Facilitator

• Dr Dimitra Panteli, Senior Management Team, European Observatory on Health Systems and Policies, Belgium

This session is organised in collaboration with the European Observatory on Health Systems and Policies.

Although lungs are the main organs involved in COVID-19, one of the major systems affected by the virus is the cardiovascular system. It is estimated that 20% of patients infected with COVID-19 do not die from pulmonary but cardiac problems. This is precisely the issue that the COVIRNA project is trying to address.

COVIRNA is a diagnostic tool that helps determine which COVID-19 patients will be at risk of developing fatal cardiovascular complications. It allows health providers to improve clinical decision-making, individualised surveillance, care and follow-up of COVID-19 patients.

Health managers play a crucial role in implementing innovative diagnostic tools such as COVIRNA into the care setting. After presenting the COVIRNA diagnostic tool, this session will therefore explore how health managers can help design patient-centred care pathways and create enabling environments for the uptake of innovative tools. This session will also discuss how patient-centered care and personalised medicine can improve health outcomes and enhance patients’ quality of life.

Speakers

• Dr Yvan Devaux, Head of the Cardiovascular Research Unit at Luxembourg Institute of Health, Luxemburg
• Dr Damien Gruson, Chief of Department of Laboratory Medicine of the St-Luc Hospital, Belgium
• Prof Sandra Buttigieg, Head of Department Health Systems Management and Leadership at the University of Malta, Malta
• Mr Ed Harding, Director of the Heart Failure Policy Network and Managing Director of The Health Policy Partnership, UK

Facilitator
Ms Anett Ruszanov, Director of Policy and Programmes, European Health Management Association (EHMA), Belgium

This session is organised in collaboration with the COVIRNA project that receives funding under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 101016072).

The presentations in this session will take on the topic of management, operations and practice in a primary care setting, addressing barriers and facilitation to integration, patient perspectives, innovation and improvement to the delivery of and engagement with primary care.

The following abstracts will be presented:

• Health service ecosystem perspective in primary care: identifying barriers and facilitation for factors of formal and informal carers integration
  Mr Federico De Luca, Politecnico di Milano, Milan, Italy
• From community empowerment to better primary healthcare. Implementation of community empowerment and engagement framework at primary health care facility in rural Kazakhstan
  Dr Rabiga Khozhamkul, Kazakh National Medical University, Almaty, Kazakhstan
• Using personal genomic data within primary care: a bioinformatics approach to pharmacogenomics
  Mr Rick Overkleeft, 4MedBox Europe B.V., Leiden, Netherlands
• The needs and expectations of occasional users of primary care services – which patients stand to gain health benefits?
  Ms Laura Pitkänen, University of Helsinki, Helsinki, Finland
• Performance measurement in healthcare including the perspective of patients: a bibliometric literature review
  Ms Sofia Silvola, LIUC – Università Cattaneo, Castellanza, Italy

This session will be moderated by Prof Naomi Chambers, Professor of Health Management at University of Manchester, United Kingdom

Well-designed, evidence-based, and result-driven healthcare policies can reduce health inequalities, support the provision of safe and high-quality patient care, and ensure the efficient use of resources, thus leading to improvements in population health. In this session presenters will discuss current cases and future trends from various countries in Europe related to solidarity, accessibility, and sustainability.

The following abstracts will be presented:

• Exploring the reporting and monitoring of adverse health events in Romania: current progress and future development
  Dr Marius Ionuț Ungureanu, Department of Public Health, Faculty of Political, Administrative and Communication Sciences, Babeș-Bolyai University, Cluj-Napoca, Romania
• The development of solidarity in the Dutch health care system between 2013 and 2021: a repeated cross-sectional study
  MSc Marloes Meijer, Netherlands Institute for Health Services Research (Nivel), Utrecht, Netherlands
• A network based approach to improve accessibility of primary care services
  Dr Chiara Morlotti, University of Bergamo, Bergamo, Italy
• Identifying medical deserts in Europe: a new working definition from the AHEAD consortium
  PhD Mirela Mustata, Center for Health Policies and Services, Bucharest, Romania
• Reducing GHG emissions, waste and costs by remanufacturing single-use medical devices
  Mr Dan Vukelich, Association of Medical Device Reprocessors, Berlin, Germany

During the pandemic, three different countries and locales started this collaborative to better understand partnership working among health and social care organizations globally. While three different countries with three different contexts and perspectives were part of the initial collaboration, we observed very similar experiences with partnership working during the pandemic. Additionally, where we observed differences, there is also opportunity for continued learning and opportunities to build upon advances in partnership working during the pandemic. This proposed session will last 75 minutes with the first 30 minutes providing an overview of the collaborative’s work to date, and the remaining 45 minutes for facilitated discussion. Main objectives of the session are:

• Discuss work and partnership process to date of the International Health and Social Care Collaborative between the United States, Belgium, and the United Kingdom.
• Identify others that are interested in joining the research and practice efforts of this collaborative.
• Solicit thoughts for expanded research, practice, and structure through this collaborative for those that may have an interest in participating.

Facilitators

• Mr Nabil Jamshed, Head of Corporate Governance, Guy’s and St. Thomas’ NHS Foundation Trust, UK
• Dr Usman Khan, Good Governance Institute, Belgium; Visiting Professor, KU Leuven, Belgium
• Prof Walter Sermeus, Full Professor, KU Leuven Institute for Healthcare Policy, Programme Director Master of Healthcare Management & Policy KU Leuven, Belgium
• Prof Kristin Wilson, Associate Professor, Saint Louis University College for Public Health & Social Justice, USA

This session is organised in collaboration with the Leuven Institute for Healthcare Policy.

In this session, the presentations will provide an insight into the current and future trends impacting the health workforce, ranging from the effect of COVID-19 on the health workplace related to professional stress management, work-life balance, pandemic risk and protection to innovative solutions with digitalisation.

The following Posters will be presented:

• Digital Transformation in Health: what words do we use?
  Mr Miguel Cabral de Pinho, MD, Public Health Unit Maia and Valongo & Portuguese Association, Portugal
• Evaluating Sustainability in Operating Hospitals – A Comparative Case Study in Germany
  Jan Apel, HSBA – Hamburg School of Business Administration, Germany
• How can task shifting elevate European health systems?
  Eszter Kovacs, Assistant Professor, Health Workforce Planning Knowledge Centre, Semmelweis University, Hungary
• The coordinated patient pathway in the French military health system: example and challenges of an integrated health system
  Mr Guillaume Cassourret, Military Hospital Fellow in Public Health, French Military Health Service, France
• Leadership and change management training for nurse managers
  Prof Zoltán Cserháti, Senior Lecturer, Semmelweis University Health Services Management Training Centre, Hungary
• Patient experiences library
  Prof Marija Jevtic, Professor, University of Novi Sad, Serbia
• Jointed Innovation Procurement to reduce healthcare and social barriers
  Ms Patrícia Couceiro, Innovation Project Manager, CHUC – Centro Hospitalar e Universitário de Coimbra, Portugal

To ensure their sustainability and resilience, health systems must anticipate future trends and challenges, as well as plan to deal with them. Although changes in healthcare tend to be slow-moving and incremental, disruptive models, technology, and processes are ever present and require swift adaptations at the European, national and organisational levels.

What are the drivers of change in health systems? What are the trends to monitor over the next years? What is the impact of these trends on healthcare delivery and health ecosystems? What role for health managers as leaders to lead and prepare for these trends?

Keynote

Dr David Somekh
Director
European Health Futures Forum (EHFF)

Panel discussion with

• Dr Dimitra Panteli, Programme Manager at the European Observatory on Health Systems and Policies
• Dr Miklós Szócska, Director of Health Services Management Training Centre, Semmelweis University